Corix Bioscience Announces Ticker Symbol Change to CXBS

Corix Bioscience Announces Ticker Symbol Change to CXBS

ID: 555068

(firmenpresse) - PHOENIX, AZ -- (Marketwired) -- 08/02/17 -- Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade oil manufacturer, today officially announced that, effective August 2, 2017, the company will commence trading on the OTCQB under the new trading symbol "CXBS." The change reflects the company's focus as a next generation developer of proprietary Cannabis and Hemp strains using tissue cell cultures in our laboratory and grows these plants to extract the oils with a focus on the pharmaceutical market. The previous trading symbol was "AHIT."

Corix Bioscience, Inc. ("Corix") is a Wyoming corporation listed as (OTCQB: CXBS) as a fully reporting SEC company. Corix is the developer of proprietary cannabis and industrial hemp strains using tissue cell cultures to propagate living plants, with plans to patent strains to be used in the pharmaceutical medical industries. Our methods allow us to create and breed new and existing plant strains from tissue cells free from any pathogens or disease. We grow these plants to maturity and extract the oils. The oils are the "medicine" part of the plant. Our sales are focused at the medical industry and are developing brand named products to be released in early 2018. Company headquarters are in Phoenix, AZ with our laboratory and processing facility in Carson City, NV and grows in Genoa, NV. We are currently looking at expanding our footprint into Washington, Oregon, California and Arizona. The Company's mission is to create clean products in medical grade facilities that are truly better for people and the environment. For more information, please visit Corix's website at

This press release, and those statements regarding IXB and the Company, contain forward-looking statements that relate to expectations, beliefs, projections, future plans and strategies, anticipated events and similar expressions. Forward-looking statements may be identified by use of words such as "may," "will," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," or "potential" or similar words or phrases which are predictions of or indicate future events or trends. Statements such as those concerning potential acquisition activity, investment objectives, strategies, opportunities, other plans and objectives for future operations or economic performance are based on the Company's current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties. You are cautioned not to place undue reliance on any forward-looking statements and the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, future events or other changes. Please refer to Company's filings with the Securities and Exchange Commission for further information.







Corix Bioscience Inc.
Christ Froese
623-551-5808


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  CannaRoyalty Investee, AltMed, Partners with Established Cultivator; Awarded Florida Medical Marijuana License InspireMD's CGuard Carotid Embolic Prevention System Featured at the SOLACI CACI Congress of Cardiology 2017 in Buenos Aires
Bereitgestellt von Benutzer: Marketwired
Datum: 02.08.2017 - 16:36 Uhr
Sprache: Deutsch
News-ID 555068
Anzahl Zeichen: 0

contact information:
Town:

PHOENIX, AZ



Kategorie:

Healthcare



Diese Pressemitteilung wurde bisher 220 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Corix Bioscience Announces Ticker Symbol Change to CXBS"
steht unter der journalistisch-redaktionellen Verantwortung von

Corix Bioscience (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Corix Enters California Cannabis Market Adding 3 Licenses ...

PHOENIX, AZ -- (Marketwired) -- 09/07/17 -- Corix Bioscience Inc. (OTCQB: CXBS) formally announces that it is acquiring 3 California cannabis licenses from California-based brand, E&B Investments LLC, for $2,000,000, consisting of $250,000 cash ...

Alle Meldungen von Corix Bioscience



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z